Skip to main content
Log in

Reply to Dr. McLeod's commentary on interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sather HN (1986) Age at diagnosis in childhood acute lymphoblastic leukemia. Med Ped Oncol 14: 166–172

    Google Scholar 

  2. Bonnefous JL, Gendre P, Guillaumont M, Frederich M, Aulagner G (1992) Determination of six thioguanine nucleotides in human red blood cells using solid-phase extraction prior to high performance liquid chromatography. J Liq Chromatogr 15: 851–861

    Google Scholar 

  3. Davies HA, Lennard L, Lilleyman JS (1993) Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? Br Med J 306: 1239–1240

    Google Scholar 

  4. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 336: 225–229

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Capdeville, R., Mousson, B. & Bax, G. Reply to Dr. McLeod's commentary on interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity. Eur J Clin Pharmacol 48, 87–88 (1995). https://doi.org/10.1007/BF00202181

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00202181

Navigation